Susquehanna Upgrades DXC Technology to Positive, Announces $42 Price Target
Susquehanna analyst James Friedman upgrades DXC Technology (NYSE:DXC) from Neutral to Positive and announces $42 price target.
JP Morgan Downgrades DXC Technology to Underweight, Raises Price Target to $45
JP Morgan analyst Tien-Tsin Huang downgrades DXC Technology (NYSE:DXC) from Neutral to Underweight and raises the price target from $42 to $45.
The Past Week’s Notable Insider Buys: ConocoPhillips, Cricut, Energy Transfer And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.
Some energy companies, including a supermajor, have seen some insider buying.
Chief executive officers were among those stepping up to the buy window during the week.
DXC Technology Q1 Adj. EPS $0.84 Beats $0.74 Estimate, Sales $4.14B Beat $4.11B Estimate
DXC Technology (NYSE:DXC) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.74 by 13.51 percent. This is a 300 percent increase over earnings of $0.21 per share from the same
Recap: DXC Technology Q1 Earnings
SShares of DXC Technology (NYSE:DXC) rose in after-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share rose 300.00% year over year to $0.84, which beat the estimate of $0.74.
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning trading, 101 companies set new 52-week highs.